S. 1784 119th Congress Senate

MAPS Act

Official title: A bill to improve coordination of Federal efforts to identify and mitigate health and national security risks through maintaining a list of essential medicines, conducting a risk assessment of essential medicine supply chains, and creating a monitoring system to map essential medicine supply chains using data analytics.

Introduced: May 15, 2025 Introduced by: Gary C. Peters Democratic · Michigan See on congress.gov

Health Computer security and identity theftCongressional oversightData collection, sharing, protectionGovernment information and archives

More subjectsShow fewer subjects

ManufacturingPrescription drugsStrategic materials and reservesSupply chain

Everywhere this bill has been 3 steps

Introduced

In committee

Reported out

Passed House

Passed Senate

To President

Became law

Mar 19, 2026

Committee on Health, Education, Labor, and Pensions. Hearings held.

May 15, 2025

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

May 15, 2025

Introduced in Senate

Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

What's happening now March 19, 2026

Committee on Health, Education, Labor, and Pensions. Hearings held.

Plain-English summary Congressional Research Service

Mapping America’s Pharmaceutical Supply Act or the MAPS Act

This bill requires the Food and Drug Administration (FDA) to continually update its essential medicines list and identify risks and vulnerabilities in the associated supply chains.

In 2020, in response to an executive order, the FDA published a list of essential medicines deemed medically necessary to have available at all times. The bill requires the FDA to update and maintain this list to include drugs and ingredients (1) related to responding to public health threats and emergency incidents, (2) of greatest priority for providing health care and at high risk of shortage, (3) the shortage of which would adversely affect patients with chronic conditions, and (4) that the Department of Defense (DOD) determines to be critical for military preparedness. The FDA must update the list at least every two years.

Also, the bill requires the FDA to conduct a risk assessment of the supply chains for drugs and ingredients on the list and annually report its findings to Congress. The assessment must include information about key manufacturing materials, drugs with primarily foreign suppliers, manufacturing capacity, relevant public health and national security risks, and risk mitigation strategies.

Additionally, the Department of Health and Human Services, in coordination with other agencies, must map and monitor relevant supply chains to identify vulnerabilities and provide an annual status report to Congress.

Finally, DOD must report to Congress every 180 days on the drugs DOD purchased that were manufactured in or sourced from China.

Hearings & markups 1

Member Day to examine S.297, to amend title XXVII of the Public Health Service Act to require group health plans and he…
Meeting Mar 19, 2026 · 10:00 AM EDT · Health, Education, Labor, and Pensions Committee

Related & companion bills 1

Bill text 1 version

Introduced in Senate Formatted Text PDF Formatted XML

Source documents hosted by congress.gov.

Committees of jurisdiction 1

Health, Education, Labor, and Pensions Committee
Senate

Lobbying activity 44

Registered lobbyists who named this bill in their disclosure filings. Source: federal Lobbying Disclosure Act filings.

THE UNITED STATES PHARMACOPEIAL CONVENTION
for THE UNITED STATES PHARMACOPEIAL CONVENTION · Maryland · 3rd Quarter 2026 (July 1 - Sep 30)
VIZIENT, INC.
for VIZIENT INC · District of Columbia · 3rd Quarter 2026 (July 1 - Sep 30)
PHLOW CORPORATION
for PHLOW CORPORATION · Virginia · 3rd Quarter 2026 (July 1 - Sep 30)
TIBER CREEK GROUP
for PHLOW CORPORATION · Virginia · 3rd Quarter 2026 (July 1 - Sep 30)
ASSOCIATION FOR ACCESSIBLE MEDICINES
for ASSOCIATION FOR ACCESSIBLE MEDICINES · District of Columbia · 3rd Quarter 2026 (July 1 - Sep 30)
ASSOCIATION FOR CLINICAL ONCOLOGY
for ASSOCIATION FOR CLINICAL ONCOLOGY · Virginia · 3rd Quarter 2026 (July 1 - Sep 30)

Bodies those filers lobbied

HOUSE OF REPRESENTATIVES
44 filings
SENATE
44 filings
Health & Human Services, Dept of (HHS)
25 filings
Centers For Medicare and Medicaid Services (CMS)
21 filings
Office of Management & Budget (OMB)
12 filings
Natl Economic Council (NEC)
10 filings
White House Office
9 filings
Commerce, Dept of (DOC)
8 filings

A filing lists the bills it worked on and the parts of government it contacted in separate sections, so these are the bodies those filers named anywhere in the filing, not a per-bill breakdown.

See all 44 filings →

Cosponsors 7